Cargando…
N-Terminal Prosomatostatin as a Risk Marker for Cardiovascular Disease and Diabetes in a General Population
CONTEXT: Somatostatin inhibits a range of hormones, including GH, insulin, and glucagon, but little is known about its role in the development of cardiometabolic disease. OBJECTIVE: The objective of the study was to investigate whether fasting plasma concentration of N-terminal prosomatostatin (NT-p...
Autores principales: | Hedbäck, Tore, Almgren, Peter, Nilsson, Peter M., Melander, Olle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010564/ https://www.ncbi.nlm.nih.gov/pubmed/27399347 http://dx.doi.org/10.1210/jc.2016-1736 |
Ejemplares similares
-
The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35)
por: van Dijk, Peter R, et al.
Publicado: (2015) -
Elevated Markers of Death Receptor-Activated Apoptosis are Associated
with Increased Risk for Development of Diabetes and Cardiovascular Disease
por: Mattisson, Ingrid Yao, et al.
Publicado: (2017) -
Polygenetic risk for coronary artery disease increases hospitalization burden and mortality
por: Sjögren, Marketa, et al.
Publicado: (2019) -
Methodological considerations for identifying multiple plasma proteins associated with all-cause mortality in a population-based prospective cohort
por: Drake, Isabel, et al.
Publicado: (2021) -
Polygenic Risk Score for Coronary Heart Disease Modifies the Elevated Risk by Cigarette Smoking for Disease Incidence
por: Hindy, George, et al.
Publicado: (2018)